Rydex Biotechnology Fund Class A (RYBOX)

NASDAQ · Mutual Fund · Delayed Price · Currency is USD
53.56
+0.23 (0.43%)
Jun 18, 2025, 4:00 PM EDT
-17.08%
Fund Assets 117.21M
Expense Ratio 1.65%
Min. Investment $2,500
Turnover n/a
Dividend (ttm) 9.42
Dividend Yield 16.76%
Dividend Growth n/a
Payout Frequency n/a
Ex-Dividend Date Dec 12, 2024
Previous Close 53.33
YTD Return -1.89%
1-Year Return -3.38%
5-Year Return 3.64%
52-Week Low 47.03
52-Week High 71.55
Beta (5Y) n/a
Holdings 79
Inception Date Sep 1, 2004

About RYBOX

The Fund's investment strategy focuses on Health/Biotech with 1.73% total expense ratio. The minimum amount to invest in Rydex Series Funds: Biotechnology Fund; A-Class Shares is $2,500 on a standard taxable account. Rydex Series Funds: Biotechnology Fund; A-Class Shares seeks capital appreciation by investing in companies that are involved in the biotechnology industry.

Category Health
Stock Exchange NASDAQ
Ticker Symbol RYBOX
Share Class Class A
Index S&P 500 TR

Performance

RYBOX had a total return of -3.38% in the past year, including dividends. Since the fund's inception, the average annual return has been 9.30%.

Equivalent Funds

These are funds that follow the same index from the other major fund companies.

Symbol Provider Name Expense Ratio
FIKCX Fidelity Fidelity Advisor Health Care Fund - Class Z 0.59%
FSPHX Fidelity Fidelity Select Health Care Portfolio 0.63%
FIJYX Fidelity Fidelity Advisor Biotechnology Fund - Class Z 0.61%
FACDX Fidelity Fidelity Advisor Health Care Fund - Class A 0.98%
FSHCX Fidelity Fidelity Select Health Care Services Portfolio 0.67%

Other Share Classes

These are alternative share classes of the same fund, from the same provider.

Symbol Share Class Expense Ratio
RYOIX Investor Class 1.40%
RYOAX Class H 1.65%
RYCFX Class C 2.40%

Top 10 Holdings

37.60% of assets
Name Symbol Weight
AbbVie Inc. ABBV 7.26%
Amgen Inc. AMGN 4.84%
Vertex Pharmaceuticals Incorporated VRTX 4.60%
Gilead Sciences, Inc. GILD 4.55%
Regeneron Pharmaceuticals, Inc. REGN 3.58%
Corteva, Inc. CTVA 3.18%
Alnylam Pharmaceuticals, Inc. ALNY 2.83%
BeOne Medicines Ltd. ONC 2.35%
First American Government Obligations Fund FGXXX 2.24%
AstraZeneca PLC AZN 2.19%
View More Holdings

Dividend History

Ex-Dividend Amount Pay Date
Dec 12, 2024 $9.42277 Dec 12, 2024
Dec 20, 2022 $0.89943 Dec 20, 2022
Dec 8, 2021 $15.77303 Dec 8, 2021
Dec 9, 2020 $6.95038 Dec 9, 2020
Dec 10, 2019 $3.60206 Dec 10, 2019
Dec 11, 2018 $9.88842 Dec 11, 2018
Full Dividend History